{
    "clinical_study": {
        "@rank": "151221", 
        "acronym": "COME", 
        "arm_group": [
            {
                "arm_group_label": "Sleep only", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo given at night to tetraplegic individuals before going to sleep,"
            }, 
            {
                "arm_group_label": "Melatonin", 
                "arm_group_type": "Active Comparator", 
                "description": "Melatonin given at night to tetraplegic individuals before going to sleep."
            }
        ], 
        "brief_summary": {
            "textblock": "The main aim is to examine the influence of daylight and melatonin on the temporal\n      variations of hemostatic factors with key roles in the hemostatic process and its\n      regulation. Particular emphasis will be on exploring the role of melatonin in hemostasis by\n      comparing subjects with tetraplegia with able-bodied control subjects."
        }, 
        "brief_title": "The Role of Melatonin in the Regulation of Blood Coagulation", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Spinal Cord Injured, Tetraplegia", 
        "condition_browse": {
            "mesh_term": "Quadriplegia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Intervention group:\n\n          -  A diagnosis of tetraplegia for at least 2 years, and otherwise healthy.\n\n          -  Must not use drugs permanently (except anti-spasmolytics).\n\n          -  Must be able to swallow tablets.\n\n          -  Must give written consent to participate.\n\n        Control group:\n\n          -  Must be healthy.\n\n          -  Must not use drugs permanently.\n\n          -  Must give written consent to participate.\n\n        Exclusion Criteria:\n\n        Both groups:\n\n          -  Those with acute or chronic co-morbidity.\n\n          -  Unable to cooperate.\n\n          -  Not provided written consent to participate."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01741389", 
            "org_study_id": "2009/295"
        }, 
        "intervention": {
            "arm_group_label": "Melatonin", 
            "intervention_name": "Melatonin (\"Circadin\")", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Melatonin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Circadian variation, hemostasis, melatonin, tetraplegia", 
        "lastchanged_date": "March 9, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Nesodden", 
                    "country": "Norway", 
                    "zip": "1450"
                }, 
                "name": "Sunnaas Hospital"
            }
        }, 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Role of Melatonin in the Regulation of Blood Coagulation", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Norway: Regional Ethics Commitee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Circadian variation of hemostatic factors", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "reference": [
            {
                "PMID": "16879232", 
                "citation": "Dahm A, Osterud B, Hjeltnes N, Sandset PM, Iversen PO. Opposite circadian rhythms in melatonin and tissue factor pathway inhibitor type 1: does daylight affect coagulation? J Thromb Haemost. 2006 Aug;4(8):1840-2."
            }, 
            {
                "PMID": "21297449", 
                "citation": "Kostovski E, Dahm AE, Iversen N, Hjeltnes N, \u00d8sterud B, Sandset PM, Iversen PO. Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium. Blood Coagul Fibrinolysis. 2011 Jun;22(4):254-9. doi: 10.1097/MBC.0b013e3283442ce2."
            }, 
            {
                "PMID": "16139333", 
                "citation": "Dahm AE, Iversen PO, Hjeltnes N, Sandset PM. Differences in circadian variations of tissue factor pathway inhibitor type 1 between able-bodied and spinal cord injured. Thromb Res. 2006;118(2):281-7. Epub 2005 Aug 31."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01741389"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Oslo", 
            "investigator_full_name": "Per Ole Iversen, MD", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Oslo", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Sunnaas Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Oslo University Hospital", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Oslo", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}